Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A

Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A
Author :
Publisher : Academic Press
Total Pages : 244
Release :
ISBN-10 : 9780323853224
ISBN-13 : 0323853226
Rating : 4/5 (226 Downloads)

Book Synopsis Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A by :

Download or read book Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A written by and published by Academic Press. This book was released on 2021-03-28 with total page 244 pages. Available in PDF, EPUB and Kindle. Book excerpt: Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems, Part A presents a collation of chapters written by global, eminent scientists. CRISPR-Cas9 system is an RNA-mediated immune system of bacteria and archaea that protects from bacteriophage infections. It is one of the revolutionized technologies to uplift biology to the next stages. Chapters in this release include An Introduction and applications of CRISPR-Cas Systems, History, evolution and classification of CRISPR-Cas associated systems, CRISPR based bacterial genome editing and removal of pathogens, CRISPR based genome editing and removal of human viruses, CRISPR based development of RNA editing and diagnostic platform, and much more. Additional sections cover Genome engineering in insects for control of vector borne diseases, Development of insect cell line using CRISPR technology, CRISPRing protozoan parasites to better understand the biology of diseases, CRISPR based genome editing of Caenorhabditis elegans, and a variety of other important topics. Offers a basic understanding and clear picture of genome editing CRISPR-Cas systems in different organisms Explains how to create an animal model for disease diagnosis/research and reprogram CRISPR for removal of virus, bacteria, fungi, protozoan, and many more Discusses the advances, patents, applications, challenges and opportunities in CRISPR-Cas9 systems in basic sciences, biomedicine, virology, bacteriology, molecular biology, and many more


Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A Related Books

Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part A
Language: en
Pages: 244
Authors:
Categories: Science
Type: BOOK - Published: 2021-03-28 - Publisher: Academic Press

DOWNLOAD EBOOK

Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems, Part A presents a collation of chapters written by global, eminent scientists. CR
Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part B
Language: en
Pages: 200
Authors:
Categories: Science
Type: BOOK - Published: 2021-04-29 - Publisher: Academic Press

DOWNLOAD EBOOK

Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems Part B, represents the collation of chapters written by eminent scientists worldwi
Reprogramming the Genome: Applications of CRISPR-Cas in non-mammalian systems part B
Language: en
Pages: 0
Authors:
Categories: Science
Type: BOOK - Published: 2021-04-30 - Publisher: Academic Press

DOWNLOAD EBOOK

Reprogramming the Genome: Applications of CRISPR-Cas in Non-mammalian Systems Part B, represents the collation of chapters written by eminent scientists worldwi
Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy
Language: en
Pages: 394
Authors:
Categories: Science
Type: BOOK - Published: 2021-06-12 - Publisher: Academic Press

DOWNLOAD EBOOK

Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy, presents the collation of chapters written by eminent scientists worldwide. CRISPR-Cas9 is a k
CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A
Language: en
Pages: 310
Authors:
Categories: Science
Type: BOOK - Published: 2024-09-11 - Publisher: Elsevier

DOWNLOAD EBOOK

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems a